Karlheinz Holzmann

6.4k total citations
83 papers, 3.4k citations indexed

About

Karlheinz Holzmann is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Karlheinz Holzmann has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 21 papers in Oncology and 16 papers in Genetics. Recurrent topics in Karlheinz Holzmann's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Karlheinz Holzmann is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Karlheinz Holzmann collaborates with scholars based in Germany, United States and United Kingdom. Karlheinz Holzmann's co-authors include Rainer Porschen, Michael Gregor, Bodo Klump, Hans A. Kestler, F Borchard, Chih‐Jen Hsieh, Lars Bullinger, Hartmut Döhner, Thomas M. Gress and C.‐J. Hsieh and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Karlheinz Holzmann

80 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karlheinz Holzmann Germany	32	1.6k	800	723	575	503	83	3.4k
Michael Zimmer United States	24	1.6k 1.1×	711 0.9×	817 1.1×	370 0.6×	690 1.4×	52	3.1k
Sandra Ryeom United States	32	2.3k 1.5×	993 1.2×	742 1.0×	631 1.1×	163 0.3×	71	4.4k
Pascal Colosetti France	27	2.4k 1.6×	770 1.0×	580 0.8×	332 0.6×	179 0.4×	48	3.3k
Peter Bugert Germany	32	2.1k 1.4×	479 0.6×	1.1k 1.5×	216 0.4×	147 0.3×	147	3.8k
Azeddine Atfi France	39	3.1k 2.0×	1.1k 1.3×	660 0.9×	292 0.5×	299 0.6×	87	4.4k
Bernhard Hemmerlein Germany	29	1.7k 1.1×	629 0.8×	635 0.9×	348 0.6×	193 0.4×	90	3.1k
Sandya Liyanarachchi United States	40	3.5k 2.2×	860 1.1×	2.1k 2.9×	372 0.6×	456 0.9×	86	5.4k
Eric A. Severson United States	25	2.0k 1.3×	1.5k 1.8×	1.2k 1.6×	861 1.5×	363 0.7×	127	4.3k
Ramin Radpour Switzerland	30	1.3k 0.8×	595 0.7×	704 1.0×	565 1.0×	216 0.4×	72	2.7k

Countries citing papers authored by Karlheinz Holzmann

Since Specialization

Citations

This map shows the geographic impact of Karlheinz Holzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karlheinz Holzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karlheinz Holzmann more than expected).

Fields of papers citing papers by Karlheinz Holzmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karlheinz Holzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karlheinz Holzmann. The network helps show where Karlheinz Holzmann may publish in the future.

Co-authorship network of co-authors of Karlheinz Holzmann

This figure shows the co-authorship network connecting the top 25 collaborators of Karlheinz Holzmann. A scholar is included among the top collaborators of Karlheinz Holzmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karlheinz Holzmann. Karlheinz Holzmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jahn, Nikolaus, Maral Saadati, Pierre Fenaux, et al.. (2023). Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia. 37(11). 2187–2196. 22 indexed citations

Hoffrogge, Raimund, et al.. (2023). Hyperthermic shift and cell engineering increase small extracellular vesicle production in HEK293F cells. Biotechnology and Bioengineering. 121(3). 942–958. 1 indexed citations

Kustermann, Monika, Jianing Liu, Wolfram Osen, et al.. (2022). Adoptively Transferred in vitro-Generated Myeloid-Derived Suppressor Cells Improve T-Cell Function and Antigen-Specific Immunity after Traumatic Lung Injury. Journal of Innate Immunity. 15(1). 78–95. 3 indexed citations

Edelmann, Jennifer, Karlheinz Holzmann, D. Britton, et al.. (2021). Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways. iScience. 24(2). 102089–102089. 16 indexed citations

Edelmann, Jennifer, Karlheinz Holzmann, David J. Britton, et al.. (2019). Rituximab and Obinutuzumab Induce Direct B-Cell Death Via B-Cell Receptor (BCR) Signaling, but Rituximab Elicits Stronger BCR-Derived Pro-Survival Signals Diminishing Apoptosis. Blood. 134(Supplement_1). 1579–1579. 2 indexed citations

Weis, Benjamin L., Simon Fischer, Silke Wissing, et al.. (2018). Stable miRNA overexpression in human CAP cells: Engineering alternative production systems for advanced manufacturing of biologics using miR‐136 and miR‐3074. Biotechnology and Bioengineering. 115(8). 2027–2038. 8 indexed citations

Barth, Thomas F.E., Johann M. Kraus, Ludwig Lausser, et al.. (2017). Comparative gene-expression profiling of the large cell variant of gastrointestinal marginal-zone B-cell lymphoma. Scientific Reports. 7(1). 5963–5963. 6 indexed citations

Perkhofer, Lukas, Karolin Walter, Ivan G. Costa, et al.. (2016). Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Stem Cell Research. 17(2). 367–378. 29 indexed citations

Richter, Julia, Kalim Ullah, Pengfei Xu, et al.. (2014). Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients. International Journal of Cancer. 136(12). 2799–2810. 29 indexed citations

10.

Herrmann, Markus D., Jochen K. Lennerz, Lars Bullinger, et al.. (2013). Transitory dasatinib-resistant states in KITmut t(8;21) acute myeloid leukemia cells correlate with altered KIT expression. Experimental Hematology. 42(2). 90–100. 9 indexed citations

11.

Pannicke, Ulrich, Bernd Baumann, Sebastian Fuchs, et al.. (2013). Deficiency of Innate and Acquired Immunity Caused by an IKBKB Mutation. New England Journal of Medicine. 369(26). 2504–2514. 121 indexed citations

12.

Holzmann, Karlheinz, et al.. (2012). High‐resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B‐cell lymphoma and its large cell variant. International Journal of Cancer. 132(3). E116–27. 18 indexed citations

13.

Sander, Sandrine, Dinis Pedro Calado, Lakshmi Srinivasan, et al.. (2012). Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis. Cancer Cell. 22(2). 167–179. 207 indexed citations

14.

Meyer, Lüder Hinrich, Manon Queudeville, Johann M. Kraus, et al.. (2011). Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways. Cancer Cell. 19(2). 206–217. 60 indexed citations

15.

Stegelmann, Frank, Lars Bullinger, Martin Grießhammer, et al.. (2009). High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations. Haematologica. 95(4). 666–669. 35 indexed citations

16.

Bullinger, Lars, Jan Krönke, Christian Schön, et al.. (2009). Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia. 24(2). 438–449. 91 indexed citations

17.

Kohlhammer, Holger, Carsten Schwäenen, Swen Weßendorf, et al.. (2004). Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood. 104(3). 795–801. 96 indexed citations

18.

Nehls, Oliver, Bodo Klump, Karlheinz Holzmann, et al.. (1999). Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma. Cancer. 85(12). 2541–2548. 1 indexed citations

19.

Holzmann, Karlheinz, Bodo Klump, F Borchard, et al.. (1998). Comparative analysis of histology, DNA content,p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. International Journal of Cancer. 76(1). 1–6. 78 indexed citations

20.

Müllenbach, Roman, Carsten M. Pusch, Karlheinz Holzmann, Ron F. Suijkerbuijk, & Nikolaus Blin. (1996). Distribution and linkage of repetitive clusters from the heterochromatic region of human chromosome 22. Chromosome Research. 4(4). 282–287. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact